• Half Year Results 2024

    DKSH Reaffirms Consistent Track Record of Creating Value in Asia and Beyond

Industries we serve globally Explore our Business Units

Key topics of interest

Insights

Insights

Get the latest insights from our experts as well as stories of where we have made an impact for our business partners.

Sustainability

Sustainability

Read our latest stories, annual reports and learn more about our approach to sustainability.

Women At DKSH

Women at DKSH

Meet some of the great women working at DKSH today.

Did you know that...?

DKSH facts and figures 2023

News

DKSH Reports Core EBIT Growth of 8.2% at CER for H1 – Reaffirming Consistent Track Record of Creating Value in Asia and Beyond

Continued value creation in H1 2024 Core EBIT increased by 8.2% (at CER1) to CHF 163.6 million  Core EBIT margin expanded by 10 basis points to 3.0% Net sales grew by 3.3% (at CER) to CHF 5.4 billion  Consumer Goods Core EBIT margin reached mid-term target of 2.5% Strong Free Cash Flow of CHF 160.8 million (cash conversion 136.0%) Confirmed outlook for 2024 Capital Markets Day on November 18 in London

DKSH Performance Materials Expands its Life Science Business in Malaysia by Acquiring Elite Organic Sdn. Bhd.

DKSH has today announced to have signed an agreement to acquire Elite Organic Sdn. Bhd. (Elite Organic) in Malaysia today. With this transaction, DKSH Performance Materials expands its capabilities in the highly attractive pharmaceuticals, foods, and nutraceutical markets, and strengthens its position as a leading specialty chemicals and ingredients distributor in Asia Pacific.

DKSH’s 91st Annual General Meeting 2024

Shareholders approved all motions with a clear majority All current Board members reelected Proposal of dividend increase of 4.7% to CHF 2.25 per share accepted

Select a market